Search research articles
Contact Us
Filters
Showing results (1-10 of 11) with videos related to
Page
of 2
Sort By:
Pharmacoeconomics
|
November 9, 2020
Comment on "Market Exclusivity for Drugs with Multiple Orphan Approvals (1983-2017) and Associated Budget Impact in the US"
Richard Manning
Health Affairs (Project Hope)
|
October 7, 2011
Brand-name versus generic drugs
Richard Manning, Richard Smith
Pharmacoeconomics
|
June 20, 2008
Pharmaceutical risk-sharing agreements
Joseph P Cook, John A Vernon, Richard Manning
Journal of Chiropractic Medicine
|
June 23, 2016
Confirmatory Factor Analysis and Multiple Linear Regression of the Neck Disability Index: Assessment If Subscales Are Equally Relevant in Whiplash and Nonspecific Neck Pain
Arthur C Croft, Bryce Milam, Jade Meylor, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases
|
June 23, 2009
Extrapulmonary tuberculosis in Kabul, Afghanistan: a hospital-based retrospective review
Tim Fader, John Parks, Najeeb Ullah Khan, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis
|
April 1, 2006
Antithrombin Nagasaki (Ser 116 to Pro): a rare antithrombin variant with abnormal heparin binding presenting during pregnancy
James S O'Ddonnell, Larry Hinkson, Andrew McCarthy, et al.
Intractable & Rare Diseases Research
|
May 20, 2016
Dietary supplement use and nosebleeds in hereditary haemorrhagic telangiectasia - an observational study
Basel Chamali, Helen Finnamore, Richard Manning, et al.
Acta Haematologica
|
June 6, 2015
A Novel Homozygous c.800C>G Substitution in GP1BA Exon 2 in a Kuwaiti Family with Bernard-Soulier Syndrome
Abdul Shlebak, Anthony Poles, Richard Manning, et al.
Health Economics
|
July 12, 2002
The benefits of switching smoking cessation drugs to over-the-counter status
Theodore E Keeler, Teh-wei Hu, Alison Keith, et al.
Transfusion
|
September 8, 2016
Risk-based decision making and ethical considerations in donor compensation for plasma-derived medicinal products
Mark W Skinner, P Ann Hedlund Hoppe, Henry G Grabowski, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 11) with videos related to
Sort By:
Page
of 2
Pharmacoeconomics
|
November 9, 2020
Comment on "Market Exclusivity for Drugs with Multiple Orphan Approvals (1983-2017) and Associated Budget Impact in the US"
Richard Manning
Health Affairs (Project Hope)
|
October 7, 2011
Brand-name versus generic drugs
Richard Manning, Richard Smith
Pharmacoeconomics
|
June 20, 2008
Pharmaceutical risk-sharing agreements
Joseph P Cook, John A Vernon, Richard Manning
Journal of Chiropractic Medicine
|
June 23, 2016
Confirmatory Factor Analysis and Multiple Linear Regression of the Neck Disability Index: Assessment If Subscales Are Equally Relevant in Whiplash and Nonspecific Neck Pain
Arthur C Croft, Bryce Milam, Jade Meylor, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases
|
June 23, 2009
Extrapulmonary tuberculosis in Kabul, Afghanistan: a hospital-based retrospective review
Tim Fader, John Parks, Najeeb Ullah Khan, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis
|
April 1, 2006
Antithrombin Nagasaki (Ser 116 to Pro): a rare antithrombin variant with abnormal heparin binding presenting during pregnancy
James S O'Ddonnell, Larry Hinkson, Andrew McCarthy, et al.
Intractable & Rare Diseases Research
|
May 20, 2016
Dietary supplement use and nosebleeds in hereditary haemorrhagic telangiectasia - an observational study
Basel Chamali, Helen Finnamore, Richard Manning, et al.
Acta Haematologica
|
June 6, 2015
A Novel Homozygous c.800C>G Substitution in GP1BA Exon 2 in a Kuwaiti Family with Bernard-Soulier Syndrome
Abdul Shlebak, Anthony Poles, Richard Manning, et al.
Health Economics
|
July 12, 2002
The benefits of switching smoking cessation drugs to over-the-counter status
Theodore E Keeler, Teh-wei Hu, Alison Keith, et al.
Transfusion
|
September 8, 2016
Risk-based decision making and ethical considerations in donor compensation for plasma-derived medicinal products
Mark W Skinner, P Ann Hedlund Hoppe, Henry G Grabowski, et al.
Page
of 2